FY2025 EPS Estimates for RIGL Increased by Cantor Fitzgerald
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for Rigel Pharmaceuticals in a research note issued to investors on Wednesday, March 5th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will earn $1.32 per share for the year, up […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for Rigel Pharmaceuticals in a research note issued to investors on Wednesday, March 5th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will earn $1.32 per share for the year, up […]
